High levels of PAI-1 have been associated with shorter overall survival and poor prognosis in many cancers including breast, gastric, colorectal, pancreas, glioma, lung, kidney, prostate, liver, and bone [31,32,33,34]. This evidence concerns the gene SERPINE1 and cancer.